Both drug classes address weight loss, but through fundamentally different biological routes
When you take a GLP-1 medication like semaglutide (Wegovy, Ozempic) or liraglutide (Saxenda), it: Slows down how quickly food leaves your stomach, which keeps you feeling full for longer Signals to your brain that youre satisfied, reducing those constant thoughts about food and snacking Helps your pancreas release the right amount of insulin when your blood sugar rises These medications were initially developed for type 2 diabetes, which is why you might have heard of Ozempic being used off-label for weight loss
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
In cutting-edge weight loss programs (including those at LIVV), physicians sometimes combine GLP-1 agonists with peptides to get the best of both worlds
Tirzepatide provides sustained, around-the-clock metabolic effects but takes weeks to reach full potency
